CN104068384A - 一种安全无副作用的快速减腹部脂肪的保健食品 - Google Patents
一种安全无副作用的快速减腹部脂肪的保健食品 Download PDFInfo
- Publication number
- CN104068384A CN104068384A CN201310118796.6A CN201310118796A CN104068384A CN 104068384 A CN104068384 A CN 104068384A CN 201310118796 A CN201310118796 A CN 201310118796A CN 104068384 A CN104068384 A CN 104068384A
- Authority
- CN
- China
- Prior art keywords
- effect
- healthcare food
- safe
- healthcare
- rapidly reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 231100000957 no side effect Toxicity 0.000 title claims abstract description 6
- 235000013305 food Nutrition 0.000 title abstract description 7
- 210000000579 abdominal fat Anatomy 0.000 title abstract 3
- 235000017060 Arachis glabrata Nutrition 0.000 claims abstract description 17
- 235000010777 Arachis hypogaea Nutrition 0.000 claims abstract description 17
- 235000018262 Arachis monticola Nutrition 0.000 claims abstract description 17
- 235000020232 peanut Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 244000105624 Arachis hypogaea Species 0.000 claims description 15
- 241000219061 Rheum Species 0.000 claims description 8
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 8
- 210000002784 stomach Anatomy 0.000 claims description 8
- 235000013402 health food Nutrition 0.000 claims description 7
- 235000012054 meals Nutrition 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 239000000843 powder Substances 0.000 abstract description 5
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 240000004980 Rheum officinale Species 0.000 abstract description 3
- 235000008081 Rheum officinale Nutrition 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 241001553178 Arachis glabrata Species 0.000 abstract 2
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 206010010774 Constipation Diseases 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- -1 carrotene Chemical compound 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- HGUVPEBGCAVWID-KETMJRJWSA-N 7-O-(beta-D-glucosyl)isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1O)[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 HGUVPEBGCAVWID-KETMJRJWSA-N 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 229940086609 Lipase inhibitor Drugs 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 235000002201 avitaminosis Nutrition 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000007784 diverticulitis Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000005096 hematological system Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- HGUVPEBGCAVWID-UHFFFAOYSA-N saponarin Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)C2C(C(O)C(O)C(CO)O2)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 HGUVPEBGCAVWID-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种安全无副作用的快速减腹部脂肪的保健食品，其配方以生花生壳粉和制大黄为原料，采用打粉方法制成。保健食品或药品中各原料配比以重量百分比计，为：生花生壳粉70-98％，制大黄1-28％，按比例称取上述成分粉末，用水冲服食用。能快速清理腹部脂肪，同时也能对高血压，高血脂等起到一定的保健作用。
Description
技术领域
本发明涉及保健食品，食品和药品领域，特别是一种安全无副作用的快速减腹部脂肪的保健食品。
背景技术
目前市场上的减肥产品主要有：
一类是食欲抑制剂，作用于中枢神经系统让你不想再吃，其弊端在于可能会引发营养不良甚至厌食症；不作用于中枢神经系统的脂肪酶抑制剂，会阻断进食的脂肪在肠内吸收。其弊端在于可导致胃肠道功能紊乱、呼吸道感染、头痛、月经失调、焦虑、易疲劳等，还影响脂溶性维生素的吸收，造成脂溶性维生素缺乏。
一类是加快体内排泄，含有利尿剂、番泻叶等成分，可将人体内的水分直接从身体中转移出去。
利尿剂利用脱水来使体重暂时下降，而有减少脂肪的假象，不过停止使用后体重就会上升，并会伴随着呕吐、头晕、虚弱等引发肾功能损伤的问题。番泻叶为刺激性泻药，只适合于急性便秘，不适合于慢性、习惯性便秘；且番泻叶不能长期大量服用，应在有效剂量3-6克内短期服用。开始使用番泻叶时，较小剂量即可立竿见影，然而随着使用时间的增长，常常需要增加剂量才能见效，且停用番泻叶后不仅便秘更为严重，还会出现戒断症状，经常使用除了会损伤肠胃道的功能，也会发生肠子松弛、贫血的问题。
发明内容
本发明的目的在于提供一种安全无副作用的快速减腹部脂肪的保健食品。
以下为发明内容：
原料(1)：生花生壳
据报道，花生壳的最大成分是粗纤维，含量65.7％-79.3％，其他营养成分也很丰富，粗蛋白4.8％-7.2％，粗脂肪1.2％-1.8％，糖类如还原糖0.3％-1.8％，双糖1.7％-2.5％，戊糖16.1％-17.8％，淀粉0.7％还含有一些矿物质，如钙0.2％，磷0.06％，镁0.07％，钾0.57％，氮1.09％，铁262mg/kg，锰45mg/kg，锌13mg/kg，铜10mg/kg，硼13mg/kg，铝454mg/kg，锶262mg/kg，钡16mg/kg，钠66mg/kg。此外，花生壳中还含有一些药用成分，如贝塔谷固醇，胡萝卜素，皂草苷，木糖等。
生花生壳中的天然粗纤维主要是非水溶性纤维，能够增加粪便的体积，减少肠中食物残渣在人体内停留的时间，让排便的频率加快，可降低罹患肠癌的风险，同时可经由吸收食物中有毒物质预防便秘和憩室炎，并且减低消化道中细菌排出的毒素，保持消化系统健康，表现在：
◇增强免疫系统
◇降低胆固醇和高血压
◇降低胰岛素和三酸甘油脂
◇通便、清肠健胃
◇预防心血管疾病、癌症、糖尿病以及其它疾病
原料(2)：制大黄
对消化系统的影响
(1)泻下作用：(2)利胆、保肝(3)促进胰液分泌、抑制胰酶活性
对血液系统的影响
(1)止血作用：(2)降血脂：降低总胆固醇、甘油三酯、低密度脂蛋白、极低密度脂蛋白及过氧化脂质。
据《神农本草经》记载：大黄，味苦，寒。下瘀血，血闭，寒热，破留饮宿食，荡涤肠胃，推陈致新，通利水谷，调中化食，安和五脏。
本发明的配方范围如下：
以重量比例计：花生壳粉70-98％，制大黄1-28％，
将上述原料按比例称取，用水冲服食用，每日2-3次。
本发明的原理：
含大量粗纤维的生花生壳在补充各种营养元素的同时，还可以帮助消化，加强肠胃功能，但是吃多了可能会因无法消化而造成腹胀，生花生壳和制大黄精确配伍，既能完全享受花生壳的好处，同时也能避免腹胀的可能性。经过多次实验证明，此配方对腹部肥胖有特别明显的效果，三天可以见效，三个星期可以减掉大将军肚，同时也能对高血压，高血脂等起到一定的保健作用。日常生活中，如果觉得腹部淤堵，便秘，可以服用本配方一两次以做日常保健。
具体实施方式
将生花生壳晒干后打成粉，制大黄打成粉，再以生花生壳粉70-98％，制大黄1-28％配伍，每天服用2-3次，每次一调羹，加适量水冲服食用，如果杯中尚有残留物，再加适量水服用。
Claims (3)
1.一种安全无副作用的快速减腹部脂肪的保健食品。其特征在于所用原料组成为花生壳粉和制大黄，其重量百分比为花生壳粉70-98％，制大黄1-28％。
2.根据权利要求1所述的保健食品，其特征在于花生壳粉为生花生壳粉。
3.根据权利要求1所述的保健食品，其特征在于其重量百分比为花生壳粉70-98％，制大黄1-28％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310118796.6A CN104068384A (zh) | 2013-03-29 | 2013-03-29 | 一种安全无副作用的快速减腹部脂肪的保健食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310118796.6A CN104068384A (zh) | 2013-03-29 | 2013-03-29 | 一种安全无副作用的快速减腹部脂肪的保健食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104068384A true CN104068384A (zh) | 2014-10-01 |
Family
ID=51590301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310118796.6A Pending CN104068384A (zh) | 2013-03-29 | 2013-03-29 | 一种安全无副作用的快速减腹部脂肪的保健食品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104068384A (zh) |
-
2013
- 2013-03-29 CN CN201310118796.6A patent/CN104068384A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101606704B (zh) | 一种具有多种功能作用的膳食纤维食品 | |
| WO2011077800A1 (ja) | 高脂血症改善剤、並びに、貧血改善組成物、尿酸値低下組成物及び飲食品 | |
| KR102190556B1 (ko) | 환형 제형을 위한 다이어트용 한방 건강기능식품 조성물 | |
| CN101301080A (zh) | 用于控制体重的棒状纯天然谷物保健食品及其制备方法 | |
| CN101766274B (zh) | 含竹叶黄酮的抗氧化功能食品组合物 | |
| CN107198246A (zh) | 一种保健组合物与一种保健制剂 | |
| KR20090025638A (ko) | 항비만용 약제학적 조성물 | |
| US20140127297A1 (en) | Nutraceutical composition for limiting the absorption of dietary lipids and for inducing weight loss, comprising, as active agent, at least one extract of carrot | |
| CN101606701B (zh) | 纳豆花粉制剂 | |
| JP2011148748A (ja) | アディポネクチン分泌促進組成物 | |
| WO2016085321A2 (en) | Inhibitory compositions | |
| CN100502694C (zh) | 一种用于减肥和降血脂的海洋功能食品 | |
| KR20010103065A (ko) | 식이섬유 함유 다이어트 조성물 | |
| CN103689748A (zh) | 一种具有调节肠胃道功能，防治便秘的即冲型饮品 | |
| KR102002426B1 (ko) | 휴대용 다이어트 건강보조식품 | |
| CN104068384A (zh) | 一种安全无副作用的快速减腹部脂肪的保健食品 | |
| JP2006020606A (ja) | 肥満防止、改善のための健康食品用組成物 | |
| JP2004329047A (ja) | 栄養補助食品 | |
| WO2014016265A1 (en) | Hawthorn and phytosterols and their effect on metabolic disorders | |
| KR20150044014A (ko) | 소화흡수를 억제하는 항비만용 추출물 및 그 제조방법 | |
| KR101201286B1 (ko) | 지방, 탄수화물 및 단백질 흡수억제, 지방 축적 억제 및 지방 분해 효과를 갖는 기능성 조성물과 이를 이용한 식품 | |
| Patel et al. | A review on flax seed: A legume for longevity | |
| KR100921172B1 (ko) | 식이섬유를 함유하는 슬리밍 식품 조성물 | |
| WO2014016266A1 (en) | Kudzu and phytosterols for use in the treatment of metabolic disorders | |
| CN110089751A (zh) | 肠排保健品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhu Yanyan Document name: Notification of Publication of the Application for Invention |
|
| DD01 | Delivery of document by public notice |
Addressee: Zhu Yanyan Document name: Notification of before Expiration of Request of Examination as to Substance |
|
| DD01 | Delivery of document by public notice |
Addressee: Zhu Yanyan Document name: Notification that Application Deemed to be Withdrawn |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141001 |